Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
Blunt Fascial vs. Veress Needle Peritoneal Entry in Laparoscopic Gynecologic Surgery
for
Laparoscopic Surgery
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: Female
Age: 18+
Code: NCT06305975
Recruiting
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
for
Mitral Valve Prolapse
Location: Los Angeles CA, Kansas City MO, Cleveland OH,
Sponsor: Northwell Health
Sex: All
Age: 21+
Code: NCT06738537
Recruiting
Pulmonary Disease and Exercise Tolerance in Boys With Fabry Disease
for
Fabry Disease
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: Male
Age: 8 - 18
Code: NCT01304875
Recruiting
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
for
Metastatic Castration-resistant Prostate Cancer
Location: Los Angeles CA, Gettysburg PA
Sponsor: FutureChem
Sex: Male
Age: 18+
Code: NCT05458544
Phase1, Phase2, Recruiting
Belatacept in Heart Transplantation
for
Heart Transplant
Location: Los Angeles CA, Salt Lake City UT, Kansas City MO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT06478017
Phase2, Recruiting
Esophageal Temperature During PVI Using Q-DOT Micro
for
Atrial Fibrillation Paroxysmal
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT06392932
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Bakersfield CA, Billings MT,